Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Drug Risk Versus Benefit

Gretchen Henkel  |  April 1, 2009

Perceptions from the FDA, physicians, and patients

Filed under:Uncategorized Tagged with:BiologicsDisease-modifying antirheumatic drugs (DMARDs)FDASafety

Know Your Labs, Part 2

Peter H. Schur, MD  |  April 1, 2009

A review of testing for rheumatoid arthritis

Filed under:ConditionsRheumatoid Arthritis Tagged with:DiagnosisRheumatoid arthritisTesting

Change on the Mall

David S. Pisetsky, MD, PhD  |  March 1, 2009

Will an election driven by change bring agreeable—and affordable—healthcare reform?

Filed under:Legislation & AdvocacyOpinionRheuminationsSpeak Out Rheum Tagged with:Healthcare ReformLegislationObamaPolitics

The Gender Effect

Kurt Ullman  |  March 1, 2009

Are gender-based differences in rheumatic and autoimmune disease clinically relevant or statistical artifact?

Filed under:Conditions Tagged with:AutoimmuneGendergenetics

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Filed under:Drug Updates Tagged with:ApprovalsPipeline

Lupus in the Child’s Mind

Hermine Brunner, MD, MSc, and Marisa Klein-Gitelman, MD, MPH  |  March 1, 2009

Unique neuropsychiatric problems require a unique approach

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:DiagnosisNeurologySystemic lupus erythematosusTreatment

Electronic Prescribing: The First Step Towards an Integrated Health Delivery System?

Staff  |  February 1, 2009

With the introduction of the 2009 Centers for Medicare and Medicaid Services’ (CMS’s) electronic prescribing incentive program, the door is opening for widespread adoption of health information technology (HIT) within the physician’s practice.

Filed under:From the CollegePractice Support Tagged with:Practice Tips

Know Your Labs

Peter H. Schur, MD  |  February 1, 2009

A review of state-of-the-art testing for SLE and connective tissue disease.

Filed under:ConditionsSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:connective tissue diseaseDiagnosisSystemic lupus erythematosusTesting

ARHP Presidential Introduction

Pamela J. Degotardi, PhD  |  January 1, 2009

As the newly minted president of the ARHP, I’d like to introduce myself.

Filed under:From the CollegeProfilesResearch Rheum Tagged with:ACR NewsResearch

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Filed under:Drug Updates Tagged with:Labeling ChangesMyopathyPharmaceutical ResearchSafety

  • « Previous Page
  • 1
  • …
  • 308
  • 309
  • 310
  • 311
  • 312
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences